ArticleBMC medicine2022

Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.

Keren Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.